| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2009-11-30 15:50:49 UTC |
|---|
| Update Date | 2023-02-21 17:17:56 UTC |
|---|
| HMDB ID | HMDB0013198 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-O-Methylgallic acid |
|---|
| Description | 4-O-Methyl gallic acid (4-OMGA) has first been identified as a major methyl derivative of gallic acid in human plasma and urine. More recently, 4-O-methyl gallic acid (4-OMGA) has been found in urine during regular black tea ingestion and in plasma after moderate red wine consumption. PMID: 15527792 . 4-O-methylgallic acid (4-OMGA), a major metabolite of gallic acid abundant in red wine. 4-OMGA inhibited the expression of intercellular adhesion molecule-1(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs) stimulated with tumor necrosis factor-alpha (TNF-alpha), resulting in the suppression of leukocyte adhesion to HUVECs (PMID: 17027748 ). 4-O-Methyl gallic acid has been found to be a metabolite of Beauveria and Pantoea (PMID: 17111140 ) (https://www.researchgate.net/publication/275561863_Microbial_Degradation_of_Bergenin_a_Phenolic_C-Glucoside). |
|---|
| Structure | COC1=C(O)C=C(C=C1O)C(O)=O InChI=1S/C8H8O5/c1-13-7-5(9)2-4(8(11)12)3-6(7)10/h2-3,9-10H,1H3,(H,11,12) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-O-Methylgallate | Generator | | 3,5-Dihydroxy-4-methoxybenzoic acid | MeSH | | 4-Methoxy-3,5-dihydroxybenzoic acid | MeSH | | 4-Methoxygallic acid | MeSH | | 4OMGA CPD | MeSH | | 4-Methoxygallate | Generator, HMDB | | 3,5-Dihydroxy-4-methoxy-benzoate | HMDB | | 3,5-Dihydroxy-4-methoxy-benzoic acid | HMDB | | 3,5-Dihydroxy-4-methoxybenzoate | HMDB, Generator | | 3,5-Dihydroxy-P-anisic acid | HMDB | | 4-Methoxy-3,5-dihydroxybenzoate | HMDB | | 5-Hydroxyisovanillic acid | HMDB | | 4-O-Methylgallic acid | MeSH |
|
|---|
| Chemical Formula | C8H8O5 |
|---|
| Average Molecular Weight | 184.1461 |
|---|
| Monoisotopic Molecular Weight | 184.037173366 |
|---|
| IUPAC Name | 3,5-dihydroxy-4-methoxybenzoic acid |
|---|
| Traditional Name | 3,5-dihydroxy-4-methoxybenzoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=C(O)C=C(C=C1O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H8O5/c1-13-7-5(9)2-4(8(11)12)3-6(7)10/h2-3,9-10H,1H3,(H,11,12) |
|---|
| InChI Key | UBXDWYFLYYJQFR-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gallic acid and derivatives. Gallic acid and derivatives are compounds containing a 3,4,5-trihydroxybenzoic acid moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Gallic acid and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Gallic acid or derivatives
- P-methoxybenzoic acid or derivatives
- Methoxyphenol
- Benzoic acid
- Phenoxy compound
- Anisole
- Methoxybenzene
- Resorcinol
- Phenol ether
- Benzoyl
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Phenol
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Monocarboxylic acid or derivatives
- Organooxygen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.59 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.1076 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.19 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 86.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 998.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 308.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 78.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 165.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 61.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 360.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 327.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 207.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 677.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 193.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 965.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 202.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 588.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 258.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 325.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-O-Methylgallic acid,1TMS,isomer #1 | COC1=C(O)C=C(C(=O)O)C=C1O[Si](C)(C)C | 1814.0 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,1TMS,isomer #2 | COC1=C(O)C=C(C(=O)O[Si](C)(C)C)C=C1O | 1842.7 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,2TMS,isomer #1 | COC1=C(O[Si](C)(C)C)C=C(C(=O)O)C=C1O[Si](C)(C)C | 1845.1 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,2TMS,isomer #2 | COC1=C(O)C=C(C(=O)O[Si](C)(C)C)C=C1O[Si](C)(C)C | 1835.2 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,3TMS,isomer #1 | COC1=C(O[Si](C)(C)C)C=C(C(=O)O[Si](C)(C)C)C=C1O[Si](C)(C)C | 1882.9 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,1TBDMS,isomer #1 | COC1=C(O)C=C(C(=O)O)C=C1O[Si](C)(C)C(C)(C)C | 2119.9 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,1TBDMS,isomer #2 | COC1=C(O)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C=C1O | 2126.6 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,2TBDMS,isomer #1 | COC1=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)O)C=C1O[Si](C)(C)C(C)(C)C | 2383.3 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,2TBDMS,isomer #2 | COC1=C(O)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C=C1O[Si](C)(C)C(C)(C)C | 2339.8 | Semi standard non polar | 33892256 | | 4-O-Methylgallic acid,3TBDMS,isomer #1 | COC1=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C=C1O[Si](C)(C)C(C)(C)C | 2570.9 | Semi standard non polar | 33892256 |
|
|---|
| General References | - Oliveira MV, Badia E, Carbonneau MA, Grimaldi P, Fouret G, Lauret C, Leger CL: Potential anti-atherogenic cell action of the naturally occurring 4-O-methyl derivative of gallic acid on Ang II-treated macrophages. FEBS Lett. 2004 Nov 5;577(1-2):239-44. [PubMed:15527792 ]
- Lee G, Na HJ, Namkoong S, Jeong Kwon H, Han S, Ha KS, Kwon YG, Lee H, Kim YM: 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity. Eur J Pharmacol. 2006 Dec 3;551(1-3):143-51. Epub 2006 Sep 8. [PubMed:17027748 ]
- Hsu FL, Yang LM, Chang SF, Wang LH, Hsu CY, Liu PC, Lin SJ: Biotransformation of gallic acid by Beauveria sulfurescens ATCC 7159. Appl Microbiol Biotechnol. 2007 Mar;74(3):659-66. doi: 10.1007/s00253-006-0692-z. Epub 2006 Nov 17. [PubMed:17111140 ]
|
|---|